Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Claggett

Showing results (261-270 of 362) with videos related to

Pageof 37
Sort By:
The Journal of Infection|May 25, 2024
The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trialsKristoffer Grundtvig Skaarup, Mats Christian Højbjerg Lassen, Daniel Modin, et al.
European Journal of Heart Failure|February 19, 2024
Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: The PARAGON-HF studyMasatoshi Minamisawa, Riccardo M Inciardi, Brian Claggett, et al.
JACC. Heart Failure|July 15, 2019
Impact of Malnutrition Using Geriatric Nutritional Risk Index in Heart Failure With Preserved Ejection FractionMasatoshi Minamisawa, Sara B Seidelmann, Brian Claggett, et al.
JACC. Heart Failure|July 16, 2018
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT TrialMaja Cikes, Brian Claggett, Amil M Shah, et al.
Diabetes Care|January 8, 2016
Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) StudyMauro Gori, Deepak K Gupta, Brian Claggett, et al.
Journal of the American College of Cardiology|December 7, 2019
Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection FractionAmil M Shah, Maja Cikes, Narayana Prasad, et al.
Cardiovascular Diabetology|October 13, 2020
Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trialMagnus O Wijkman, Brian Claggett, Rafael Diaz, et al.
JACC. Heart Failure|March 14, 2021
Burden of Heart Failure Signs and Symptoms, Prognosis, and Response to Therapy: The PARAGON-HF TrialKarola Jering, Brian Claggett, Margaret M Redfield, et al.
The Journal of Infection|September 13, 2024
Corrigendum to "The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials" [J Infect 89 (2024) 106187]Kristoffer Grundtvig Skaarup, Mats Christian Højbjerg Lassen, Daniel Modin, et al.
Circulation|October 18, 2017
Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes MellitusEmil Wolsk, Brian Claggett, Rafael Diaz, et al.
Pageof 37

Showing results (261-270 of 362) with videos related to

Sort By:
Pageof 37
The Journal of Infection|May 25, 2024
The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trialsKristoffer Grundtvig Skaarup, Mats Christian Højbjerg Lassen, Daniel Modin, et al.
European Journal of Heart Failure|February 19, 2024
Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: The PARAGON-HF studyMasatoshi Minamisawa, Riccardo M Inciardi, Brian Claggett, et al.
JACC. Heart Failure|July 15, 2019
Impact of Malnutrition Using Geriatric Nutritional Risk Index in Heart Failure With Preserved Ejection FractionMasatoshi Minamisawa, Sara B Seidelmann, Brian Claggett, et al.
JACC. Heart Failure|July 16, 2018
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT TrialMaja Cikes, Brian Claggett, Amil M Shah, et al.
Diabetes Care|January 8, 2016
Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) StudyMauro Gori, Deepak K Gupta, Brian Claggett, et al.
Journal of the American College of Cardiology|December 7, 2019
Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection FractionAmil M Shah, Maja Cikes, Narayana Prasad, et al.
Cardiovascular Diabetology|October 13, 2020
Blood pressure and mortality in patients with type 2 diabetes and a recent coronary event in the ELIXA trialMagnus O Wijkman, Brian Claggett, Rafael Diaz, et al.
JACC. Heart Failure|March 14, 2021
Burden of Heart Failure Signs and Symptoms, Prognosis, and Response to Therapy: The PARAGON-HF TrialKarola Jering, Brian Claggett, Margaret M Redfield, et al.
The Journal of Infection|September 13, 2024
Corrigendum to "The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials" [J Infect 89 (2024) 106187]Kristoffer Grundtvig Skaarup, Mats Christian Højbjerg Lassen, Daniel Modin, et al.
Circulation|October 18, 2017
Increases in Natriuretic Peptides Precede Heart Failure Hospitalization in Patients With a Recent Coronary Event and Type 2 Diabetes MellitusEmil Wolsk, Brian Claggett, Rafael Diaz, et al.
Pageof 37